Prestige Consumer Healthcare (PBH) FCF Margin (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted FCF Margin of 26.55% for Q4 2025, up 31.41% on a QoQ basis from 20.2% in Q3 2025, and up 467.0% year-over-year from 4.68% in Q4 2024.
Analysis
Prestige Consumer Healthcare (PBH) FCF Margin (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare has reported FCF Margin for 16 years, with the latest figure at 26.55% in Q4 2025.
- On a quarterly basis, FCF Margin rose 467.0% year-over-year to 26.55% in Q4 2025; TTM through Dec 2025 was 24.21%, a 197.0% increase from a year earlier, with the FY2025 full-year figure at 21.38%, up 11.0% from the prior year.
- FCF Margin was 26.55% for Q4 2025 at Prestige Consumer Healthcare, up from 20.2% in the prior quarter.
- The five-year high for FCF Margin was 31.33% in Q2 2025, with the low at 16.69% in Q2 2023.
- Average FCF Margin over 5 years is 22.12%, with a median of 21.52% recorded in 2024.
- The sharpest annual moves came in 2021 and 2025: FCF Margin plunged 646 bps in 2021, then surged 1126 bps in 2025.
- Over 5 years, FCF Margin stood at 23.34% in 2021, then retreated by 17 bps to 19.29% in 2022, then grew by 27 bps to 24.57% in 2023, then slipped by 11 bps to 21.88% in 2024, then advanced by 21 bps to 26.55% in 2025.
- The last three FCF Margin figures came in at 26.55% (Q4 2025), 20.2% (Q3 2025), and 31.33% (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 16.17% |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 15.78% |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 13.27% |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | - |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 6.68% |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | 1.63% |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 18.08% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Honest Company | 604.06 Mn | 498.16 Mn | 40.36 Mn | 37.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 26.55% |
| Sep 30, 2025 | 20.20% |
| Jun 30, 2025 | 31.33% |
| Mar 31, 2025 | 19.68% |
| Dec 31, 2024 | 21.88% |
| Sep 30, 2024 | 23.88% |
| Jun 30, 2024 | 20.07% |
| Mar 31, 2024 | 23.02% |
| Dec 31, 2023 | 24.57% |
| Sep 30, 2023 | 20.79% |
| Jun 30, 2023 | 16.69% |
| Mar 31, 2023 | 19.74% |
| Dec 31, 2022 | 19.29% |
| Sep 30, 2022 | 19.07% |
| Jun 30, 2022 | 20.65% |
| Mar 31, 2022 | 22.46% |
| Dec 31, 2021 | 23.34% |
| Sep 30, 2021 | 21.16% |
| Jun 30, 2021 | 25.19% |
| Mar 31, 2021 | 22.79% |